Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $30.1000 (0.74%) ($30.1000 - $30.1000) on Mon. Sep. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.56% (three month average) | RSI | 68 | Latest Price | $30.1000(0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.3% a day on average for past five trading days. | Weekly Trend | TGTX advances 7.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(69%) ARKG(65%) ARKK(60%) IBB(60%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -2.28% in a week (0% probabilities). VIXM(-46%) VXX(-39%) UUP(-19%) IGOV(-8%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.28% (StdDev 4.56%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $30.01(0.3%) | 10 Day Moving Average | $29.44(2.24%) | 20 Day Moving Average | $27.02(11.4%) | To recent high | -25.6% | To recent low | 38.8% | Market Cap | $3.812b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |